Zon, Gerald (Author)
The year 2019 marked the 60th anniversary of the approval of cyclophosphamide (CP) as an anticancer drug by the U.S. Food & Drug Administration in 1959 for the treatment of lymphoma. Between 1959 and 2019 there were ~50,000 publications listed in PubMed that have CP in the title and/or abstract, with these annual numbers showing a continual increase, and over 1,800 such articles in 2019 alone. The discovery of CP is a prime example of serendipity in science, which also applies to key elements of the metabolism and pharmacological basis for the specificity of the cytotoxicity of CP toward cancer cells. Phosphoramide mustard, the principal metabolite of CP with DNA alkylating activity, was synthesized and reported by Friedman and Seligman in 1954 prior to the discovery of CP. Interestingly, the original drug design premise for synthesizing PM, which was based on elevated phosphamidase enzyme activity in cancer cells proved to be incorrect. While this wrong premise also led to the synthesis of CP, as a six-membered ring cyclic phosphamidase-activated precursor of PM, the actual metabolic conversion of CP to PM was subsequently found to involve a surprisingly complex array of metabolites and metabolic pathways, all completely unrelated to phosphamidase. Although the molecular structure of CP has an asymmetrically substituted, i.e. chiral phosphorus center, the racemic mixture of the Rp and Sp enantiomers of CP was used throughout its initial investigations and subsequent clinical trials despite the involvement of an initial enzyme-mediated metabolic activation step, which could, in principle, be stereoselective for only one of the enantiomers of CP. Stereochemical investigations along those lines were eventually carried out, but the results did not warrant replacement of racemic CP with either enantiomer in the clinic. Amazingly, there are now ~4,000 structural congeners of PM listed in Chemical Abstracts, but none have led to an anticancer drug superior to CP. This account provides a synopsis of the key chemistry and stereochemistry investigations that comprise this story of CP, as a remarkable instance of serendipity in science, and my chance involvement in the unfolding of this fascinating story.
...More
Article
Jack S. Cohen;
(2021)
History of Research on Antisense Oligonucleotide Analogs
(/isis/citation/CBB450691525/)
Article
Jack S. Cohen;
Peter F. Daly;
(2022)
History of Research on Phospholipid Metabolism and Applications to the Detection, Diagnosis, and Treatment of Cancer
(/isis/citation/CBB937672031/)
Article
Manuela Rizzi;
Matteo Gallazzi;
Francesca Tosetti;
Lorenzo Mortara;
(2020)
The tumor-endothelium cell interaction in pioneering studies and the revisited concept on the angiogenesis process during tumor progression and metastasis
(/isis/citation/CBB704955825/)
Article
Giulia Bovone;
(2019)
L’Arsenico: da strumento di morte ad antitumorale (XIX – XX - XXI secolo)
(/isis/citation/CBB158105733/)
Chapter
Roberto Taramelli;
(2016)
Una nuova visione del cancro attraverso le lenti della dinamica dei sistemi
(/isis/citation/CBB225293248/)
Article
Kauffman, George B.;
Adloff, Jean-Pierre;
(2013)
The Centenary of the Maillard Reaction
(/isis/citation/CBB001211975/)
Article
Marc Henry;
(2021)
Thermodynamics of Life
(/isis/citation/CBB851479700/)
Article
Pittard, A. J.;
Cox, G. B.;
(2010)
Frank William Ernest Gibson 1923--2008
(/isis/citation/CBB001022179/)
Article
Maria Benedetta Gambacorti-Passerini;
Lucia Zannini;
(2017)
La "cura": tra dimensioni terapeutiche, esistenziali ed educative
(/isis/citation/CBB648796466/)
Article
Rossella Costa;
(2017)
From Chemical to Genetic Individuality. Evolving Concepts and Therapeutic Approaches
(/isis/citation/CBB900408942/)
Article
Mauro Capocci;
(2017)
Regimen Strikes Back. Diagnosis, Genes and the Patient
(/isis/citation/CBB699749755/)
Article
Prebble, John N.;
(2010)
The Discovery of Oxidative Phosphorylation: A Conceptual Off-Shoot from the Study of Glycolysis
(/isis/citation/CBB001023965/)
Article
Junardi Harahap;
Rita Destiwati;
(2023)
"Hijrah Medicine": a study of the transition of medicine from general to Islamic-based medicine in Indonesia
(/isis/citation/CBB493281004/)
Article
Sharma, Padmanee;
Allison, James P.;
(2012)
Lloyd J. Old (1933--2011)
(/isis/citation/CBB001320473/)
Book
Cornwall, Claudia;
(2013)
Catching Cancer: The Quest for Its Viral and Bacterial Causes
(/isis/citation/CBB001213235/)
Article
Orland, Barbara;
(2012)
The Fluid Mechanics of Nutrition: Herman Boerhaave's Synthesis of Seventeenth-Century Circulation Physiology
(/isis/citation/CBB001221619/)
Article
Natasa Kustrimovic;
Daniela Gallo;
Andrea De Lerna Barbaro;
Eliana Piantanida;
Lorenzo Mortara;
Maria Laura Tanda;
(2023)
The discovery of TNF-alpha: A historical perspective
(/isis/citation/CBB446223292/)
Article
Harriet L. Crosby;
(2016)
Jane Cooke Wright (1919–2013): Pioneering Oncologist, Woman and Humanitarian
(/isis/citation/CBB951031731/)
Article
Neeraja Sankaran;
Ton van Helvoort;
(2016)
Andrewes's Christmas Fairy Tale: Atypical Thinking About Cancer Aetiology in 1935
(/isis/citation/CBB089322763/)
Book
Gregory J. Morgan;
(2022)
Cancer Virus Hunters: A History of Tumor Virology
(/isis/citation/CBB284978916/)
Be the first to comment!